Verify any claim · lenz.io
Claim analyzed
Legal“L'Oréal's CeraVe brand is facing one or more lawsuits alleging that certain CeraVe products contain benzoyl peroxide.”
Submitted by Fair Robin 7afe
The conclusion
Open in workbench →Available legal reporting supports that CeraVe is involved in multiple lawsuits concerning specific products that contain benzoyl peroxide. The named products are acne cleansers formulated with benzoyl peroxide, and litigation has been filed over them. The key caveat is that the legal theory usually concerns alleged benzene formation or contamination, not benzoyl peroxide's mere presence.
Caveats
- The lawsuits generally focus on alleged benzene formation or contamination associated with benzoyl peroxide products, not on benzoyl peroxide being unlawful by itself.
- Some cited reports are lower-authority legal-news aggregators; the strongest support comes from legal trade reporting and litigation filings.
- The claim is accurate as an existence statement, but it can be misread as describing the full theory of liability if the benzene context is omitted.
Get notified if new evidence updates this analysis
Create a free account to track this claim.
Sources
Sources used in the analysis
Law360 reports that L’Oréal USA was sued in Louisiana federal court by a consumer who alleges that “CeraVe acne washes containing benzoyl peroxide generate benzene, a known carcinogen, at levels that make the products unsafe and misbranded.” The article identifies the products as “CeraVe Acne Foaming Cream Cleanser and CeraVe Acne Foaming Cream Wash” and notes that the putative class action relies on testing results disclosed by Valisure showing benzene in benzoyl peroxide products.
“On May 28, 2025, Judge Analisa Torres of the United States District Court for the Southern District of New York appointed Bursor & Fisher, P.A. as interim co-lead counsel in the matter titled In re L’Oréal Benzoyl Peroxide Products Litigation, Case No. 24 Civ. 3137.” The firm states that “the lawsuit alleges that certain CeraVe branded acne cream and gel products formulated with benzoyl peroxide are improperly manufactured, defective, and not safe for their intended use.”
L’Oreal is facing a class action lawsuit claiming that its CeraVe benzoyl peroxide cleanser contains a dangerous level of the carcinogenic chemical benzene. The L’Oreal BPO cleansers include CeraVe Acne Foam Cream Cleanser, which has 4% benzoyl peroxide, and CeraVe Acne Foaming Cream Wash, which has 10% benzoyl peroxide. The CeraVe benzene class action lawsuit is Grossenbacher v. L’Oreal USA Inc., Case No. 2:24-cv-00663, in the U.S. District Court for the Eastern District of Louisiana.
According to allegations raised in a class action lawsuit against L’Oréal, CeraVe acne treatment products contain dangerously high levels of benzene, exposing consumers to a known human carcinogen. The complaint was filed by Holly Grossenbacher in the U.S. District Court for the Eastern District of Louisiana on March 15, seeking class action status to pursue damages on behalf of all consumers who purchased benzene-contaminated CeraVe products manufactured by L’Oréal USA, LLC. Grossenbacher alleges she and other consumers were exposed to dangerous levels of benzene in various different products that contain benzoyl peroxide, including CeraVe Acne Foam Cream Cleanser and CeraVe Acne Foaming Cream Wash.
L’Oréal finds itself embroiled in legal battles as more allegations of unsafe benzene levels in its benzoyl peroxide (BPO) acne treatments surface. The cosmetics giant faces six class action lawsuits that have been filed against CeraVe and L’Oréal. Since Valisure’s March 2024 report on benzene in acne products, at least six class action lawsuits have been filed against L’Oréal in various jurisdictions. The lawsuits claim BPO products, including CeraVe and La Roche-Posay, contain benzene at levels “hundreds of times” the FDA’s conditional limit of 2 parts per million.
By 2024–2025, multiple U.S. class actions were filed alleging that over-the-counter acne products containing benzoyl peroxide, including specific CeraVe benzoyl peroxide cleansers, can form or contain benzene. These cases typically name L'Oréal USA (CeraVe’s parent company) as defendant and allege that CeraVe benzoyl peroxide products expose consumers to benzene through degradation of benzoyl peroxide, forming the basis for product liability and consumer protection claims.
What do you think of the claim?
Your challenge will appear immediately.
Challenge submitted!
For developers
This same pipeline is available via API.
Verify your AI's output programmatically.
/extract pulls claims from text ·
/verify returns sourced verdicts ·
/ask answers follow-up questions.
Continue your research
Verify a related claim next.
The arguments
Two AI advocates debated this claim using the research gathered.
Argument for
Multiple independent reports document that L'Oréal USA (owner of CeraVe) is being sued over CeraVe acne products explicitly described as “containing benzoyl peroxide,” including a Louisiana federal putative class action naming CeraVe Acne Foaming Cream Cleanser/Wash (Source 1, Law360; Source 3, Top Class Actions; Source 4, AboutLawsuits.com). The existence of broader coordinated litigation—In re L'Oréal Benzoyl Peroxide Products Litigation—further confirms one or more lawsuits alleging that certain CeraVe-branded products are formulated with benzoyl peroxide (Source 2, Bursor & Fisher; Source 5, Cosmetics Business).
The Proponent conflates the descriptive identification of products 'containing benzoyl peroxide' with the actual legal allegation, which — as Sources 1, 3, and 4 uniformly clarify — centers on benzene generation through benzoyl peroxide degradation, not the mere presence of benzoyl peroxide as a wrongful act. The coordinated litigation title cited from Source 2, 'In re L'Oréal Benzoyl Peroxide Products Litigation,' identifies the product category at issue but does not transform the underlying allegation, which remains one of benzene contamination, meaning the claim as worded still materially misrepresents the nature of the suits.
Argument against
The claim as stated is technically imprecise because the lawsuits do not primarily allege that CeraVe products 'contain benzoyl peroxide' as a wrongful act — rather, as Sources 1, 3, and 4 clarify, the suits allege that benzoyl peroxide in those products degrades into benzene, making the core allegation about benzene contamination, not the mere presence of benzoyl peroxide. Since the claim conflates the ingredient (benzoyl peroxide) with the alleged harm (benzene generation), it fundamentally misrepresents the nature of the litigation documented across all six sources, rendering the claim as worded materially false and misleading.
The Opponent commits a straw-man by treating the motion as if it claims “benzoyl peroxide is wrongful,” when the actual wording is narrower—lawsuits “alleging that certain CeraVe products contain benzoyl peroxide”—a factual predicate explicitly stated in the reporting and pleadings summaries (Source 1, Law360; Source 3, Top Class Actions; Source 4, AboutLawsuits.com). Moreover, the existence of coordinated proceedings titled In re L'Oréal Benzoyl Peroxide Products Litigation and describing “CeraVe branded acne cream and gel products formulated with benzoyl peroxide” independently confirms that at least one lawsuit alleges benzoyl peroxide-containing CeraVe products are at issue, regardless of whether the ultimate harm theory is benzene formation (Source 2, Bursor & Fisher; Source 5, Cosmetics Business).
Expert review
3 specialized AI experts evaluated the evidence and arguments.
Expert 1 — The Logic Examiner
Sources 1, 3, and 4 describe at least one filed suit over specific CeraVe acne washes explicitly identified as “containing benzoyl peroxide,” and Source 2 further describes coordinated litigation alleging “CeraVe branded” products “formulated with benzoyl peroxide,” which logically entails that one or more lawsuits allege certain CeraVe products contain benzoyl peroxide. The opponent's objection attacks an implied claim (“benzoyl peroxide is the wrongful act”) that is not asserted; the atomic claim is a narrow existence claim about what the lawsuits allege about product formulation, so the evidence supports it.
Expert 2 — The Context Analyst
While the opponent correctly notes that the legal harm stems from benzoyl peroxide degrading into benzene, the claim itself is a simple, factual statement about the existence of lawsuits involving CeraVe products containing benzoyl peroxide (Sources 1, 2, 3). Restoring the full context of the benzene degradation theory does not make the claim false; rather, it confirms that multiple active lawsuits specifically target CeraVe's benzoyl peroxide-formulated products.
Expert 3 — The Source Auditor
The most reliable sources in this pool are Law360 (high-authority legal trade publication, Source 1) and Bursor & Fisher's court filing announcement (Source 2), both of which clearly confirm that L'Oréal's CeraVe brand is facing lawsuits in which the products at issue are explicitly described as 'containing benzoyl peroxide' — the Louisiana federal class action names 'CeraVe Acne Foaming Cream Cleanser and CeraVe Acne Foaming Cream Wash' as benzoyl peroxide products, and the consolidated SDNY litigation is titled 'In re L'Oréal Benzoyl Peroxide Products Litigation.' The opponent's argument that the claim 'misrepresents' the litigation is a semantic overreach: the atomic claim merely states that lawsuits allege 'certain CeraVe products contain benzoyl peroxide,' which is factually accurate as a description of the product category at issue — all sources confirm these products do contain benzoyl peroxide and are the subject of active litigation — making the claim straightforwardly true as worded, even if the underlying legal theory involves benzene formation rather than the mere presence of benzoyl peroxide.